Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

PUBLICATION

A standardized in vivo platform for preclinical screening of therapeutic interventions in rat thoracic spinal cord injury

September 30, 2026
Read More
PAGE

ASD Models – Shank3/F, Cntnap2-KO, Fmr1-KO 

August 12, 2026
Read More
PUBLICATION

Amyloid precursor protein induces reactive astrogliosis

April 29, 2025
Read More
POSTER

Behavioral, Electrophysiological, and Biomarker level changes in the rTG4510 Mouse Model of Alzheimer’s Disease #1259

April 1, 2025
Read More
RESEARCH UPDATES

Characterization of a Mouse Model of Rett Syndrome

March 31, 2025
Read More
POSTER

Twenty Years of Huntington’s Disease Research at PsychoGenics

March 28, 2025
Read More
POSTER

Behavioral, electrophysiological, and biomarker level changes in the rTg4510 mouse model of Alzheimer’s disease

March 27, 2025
Read More
POSTER

Comparison of Pentameric Formyl Thiophene Acetic Acid (pFTAA) staining in humans and animal models of disease

March 27, 2025
Read More
POSTER

Evaluating Locomotor and Sensory Recovery in a Cervical Spinal Cord Injury Rat Model using Standardized methods.

March 27, 2025
Read More
RESEARCH UPDATES

Evidence of Aggression in a Mouse Model of Alzheimer’s Disease

March 25, 2025
Read More
RESEARCH UPDATES

Evidence of Apathy in a Mouse Model of Huntington’s Disease

February 19, 2025
Read More